Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.21.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net revenue $ 229,774 $ 156,633 $ 644,509 $ 283,880
Cost of net revenue 99,981 90,427 290,454 154,169
Gross profit 129,793 66,206 354,055 129,711
Operating expenses:        
Research and development 67,538 55,816 205,120 109,489
Selling, general and administrative 38,469 41,685 110,823 93,787
Impairment losses 0 0 0 86
Restructuring charges 0 3,280 2,204 3,833
Total operating expenses 106,007 100,781 318,147 207,195
Income (loss) from operations 23,786 (34,575) 35,908 (77,484)
Interest income 28 27 46 283
Interest expense (2,649) (3,569) (10,596) (8,228)
Loss on extinguishment of debt 0 0 (5,221) 0
Other income (expense), net (105) (719) (746) (620)
Total other income (expense), net (2,726) (4,261) (16,517) (8,565)
Income (loss) before income taxes 21,060 (38,836) 19,391 (86,049)
Income tax provision (benefit) 11,802 (2,191) 5,598 (12,128)
Net income (loss) $ 9,258 $ (36,645) $ 13,793 $ (73,921)
Earnings Per Share [Abstract]        
Basic (usd per share) $ 0.12 $ (0.50) $ 0.18 $ (1.02)
Diluted (usd per share) $ 0.12 $ (0.50) $ 0.17 $ (1.02)
Shares used to compute net income (loss) per share:        
Basic (shares) 76,582 73,402 75,795 72,729
Diluted (shares) 79,815 73,402 79,048 72,729